These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8581426)

  • 1. On the conformation of Phe78 of a chromoprotein antibiotic, neocarzinostatin.
    Imajo S; Ishiguro M; Tanaka T; Hirama M; Teplyakov A
    Bioorg Med Chem; 1995 Apr; 3(4):429-36. PubMed ID: 8581426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of a novel chromoprotein derived from apo-neocarzinostatin and a synthetic chromophore.
    Urbaniak MD; Muskett FW; Finucane MD; Caddick S; Woolfson DN
    Biochemistry; 2002 Oct; 41(39):11731-9. PubMed ID: 12269815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of neocarzinostatin, an antitumor protein-chromophore complex.
    Kim KH; Kwon BM; Myers AG; Rees DC
    Science; 1993 Nov; 262(5136):1042-6. PubMed ID: 8235619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling study of the structure of the macromolecular antitumor antibiotic neocarzinostatin. Origin of the stabilization of the chromophore.
    Ishiguro M; Imajo S; Hirama M
    J Med Chem; 1991 Aug; 34(8):2366-73. PubMed ID: 1831507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of apo-neocarzinostatin at 0.15-nm resolution.
    Teplyakov A; Obmolova G; Wilson K; Kuromizu K
    Eur J Biochem; 1993 Apr; 213(2):737-41. PubMed ID: 8477746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of the nonprotein chromophore of neocarzinostatin to deoxyribonucleic acid.
    Povirk LF; Goldberg IH
    Biochemistry; 1980 Oct; 19(21):4773-80. PubMed ID: 6448634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential 1H NMR assignment of the complex of aponeocarzinostatin with ethidium bromide and investigation of protein-drug interactions in the chromophore binding site.
    Mohanty S; Sieker LC; Drobny GP
    Biochemistry; 1994 Sep; 33(35):10579-90. PubMed ID: 8075058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore.
    Tanaka T; Fukuda-Ishisaka S; Hirama M; Otani T
    J Mol Biol; 2001 May; 309(1):267-83. PubMed ID: 11491295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evolution of the binding specificity of neocarzinostatin, an enediyne-binding chromoprotein.
    Heyd B; Pecorari F; Collinet B; Adjadj E; Desmadril M; Minard P
    Biochemistry; 2003 May; 42(19):5674-83. PubMed ID: 12741824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key interactions in the immunoglobulin-like structure of apo-neocarzinostatin: evidence from nuclear magnetic resonance relaxation data and molecular dynamics simulations.
    Izadi-Pruneyre N; Quiniou E ; Blouquit Y; Perez J; Minard P; Desmadril M; Mispelter J; Adjadj E
    Protein Sci; 2001 Nov; 10(11):2228-40. PubMed ID: 11604530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced formation of a DNA bulge structure by a molecular wedge ligand-postactivated neocarzinostatin chromophore.
    Gao X; Stassinopoulos A; Ji J; Kwon Y; Bare S; Goldberg IH
    Biochemistry; 2002 Apr; 41(16):5131-43. PubMed ID: 11955061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer modeling analysis for enediyne chromophore-apoprotein complex of macromolecular antitumor antibiotic C-1027.
    Okuno Y; Otsuka M; Sugiura Y
    J Med Chem; 1994 Jul; 37(15):2266-73. PubMed ID: 8057275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective proteolytic activity of the antitumor agent kedarcidin.
    Zein N; Casazza AM; Doyle TW; Leet JE; Schroeder DR; Solomon W; Nadler SG
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8009-12. PubMed ID: 8367457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid bilayer-assisted release of an enediyne antibiotic from neocarzinostatin chromoprotein.
    Hariharan P; Sudhahar CG; Chou SH; Chin DH
    Biochemistry; 2010 Sep; 49(35):7722-32. PubMed ID: 20712297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neocarzinostatin: selective tryptophan oxidation and neocarzinostatin-chromophore binding to apo-neocarzinostatin.
    Edo K; Saito K; Matsuda Y; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
    Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):170-6. PubMed ID: 1828722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, production, and characterization of recombinant neocarzinostatin apoprotein in Escherichia coli.
    Nozaki S; Tomioka Y; Hishinuma T; Inoue M; Nagumo Y; Tsuruta LR; Hayashi K; Matsumoto T; Kato Y; Ishiwata S; Itoh K; Suzuki T; Hirama M; Mizugaki M
    J Biochem; 2002 May; 131(5):729-38. PubMed ID: 11983081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteolytic specificity of the natural enediyne-containing chromoproteins is unique to each chromoprotein.
    Zein N; Reiss P; Bernatowicz M; Bolgar M
    Chem Biol; 1995 Jul; 2(7):451-5. PubMed ID: 9383447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR studies of the post-activated neocarzinostatin chromophore-DNA complex. Conformational changes induced in drug and DNA.
    Gao X; Stassinopoulos A; Gu J; Goldberg IH
    Bioorg Med Chem; 1995 Jun; 3(6):795-809. PubMed ID: 7582957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of daunomycin complexed to d-TGATCA by two-dimensional nuclear magnetic resonance spectroscopy.
    Barthwal R; Sharma U; Srivastava N; Jain M; Awasthi P; Kaur M; Barthwal SK; Govil G
    Eur J Med Chem; 2006 Jan; 41(1):27-39. PubMed ID: 16293348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential 1H, 13C, and 15N NMR assignments and solution conformation of apokedarcidin.
    Constantine KL; Colson KL; Wittekind M; Friedrichs MS; Zein N; Tuttle J; Langley DR; Leet JE; Schroeder DR; Lam KS
    Biochemistry; 1994 Sep; 33(38):11438-52. PubMed ID: 7918358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.